Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
Ahmed Kandeil, Ahmed Mostafa, Omnia Kutkat, et al.
Pathogens (2021) Vol. 10, Iss. 6, pp. 758-758
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Polyphenols: From Theory to Practice
A Bertelli, Marco Biagi, Maddalena Corsini, et al.
Foods (2021) Vol. 10, Iss. 11, pp. 2595-2595
Open Access | Times Cited: 114
Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights
Dalia Elebeedy, Walid F. Elkhatib, Ahmed Kandeil, et al.
RSC Advances (2021) Vol. 11, Iss. 47, pp. 29267-29286
Open Access | Times Cited: 106
Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 75
Hesperidin Is a Potential Inhibitor against SARS-CoV-2 Infection
Fang‐Ju Cheng, Thanh-Kieu Huynh, Chia‐Shin Yang, et al.
Nutrients (2021) Vol. 13, Iss. 8, pp. 2800-2800
Open Access | Times Cited: 99
Antiviral Properties of Polyphenols from Plants
Katarzyna Chojnacka, Dawid Skrzypczak, Grzegorz Izydorczyk, et al.
Foods (2021) Vol. 10, Iss. 10, pp. 2277-2277
Open Access | Times Cited: 86
Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
Amal Mahmoud, Ahmed Mostafa, Ahmed A. Al‐Karmalawy, et al.
Heliyon (2021) Vol. 7, Iss. 9, pp. e07962-e07962
Open Access | Times Cited: 78
Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
Heba A. El Gizawy, Sylvia A. Boshra, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5844-5844
Open Access | Times Cited: 73
Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors
Amr El‐Demerdash, Ahmed A. Al‐Karmalawy, Tarek Mohamed Abd El‐Aziz, et al.
RSC Advances (2021) Vol. 11, Iss. 50, pp. 31339-31363
Open Access | Times Cited: 69
Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
Ahmed A. Al‐Karmalawy, Mai M. Farid, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6559-6559
Open Access | Times Cited: 69
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 68
Effectiveness of Natural Antioxidants against SARS-CoV-2? Insights from the In-Silico World
Muhammad Fayyaz ur Rehman, Shahzaib Akhter, Aima Iram Batool, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 1011-1011
Open Access | Times Cited: 64
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies
Chao Ma, Mohammed S. Taghour, Amany Belal, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 56
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design,in silico,in vitro, and SAR studies for lead optimization
Maha M. Abdel‐Fattah, Khaled M. Darwish, Raya Soltane, et al.
RSC Advances (2021) Vol. 11, Iss. 56, pp. 35536-35558
Open Access | Times Cited: 56
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 56
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 55
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 47
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 40
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 32
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
Zhonglei Wang, Liyan Yang
Nutrients (2023) Vol. 15, Iss. 15, pp. 3443-3443
Open Access | Times Cited: 25
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways
Mona F. El-Azab, Ahmed A. Al‐Karmalawy, Samar A. Antar, et al.
Life Sciences (2022) Vol. 303, pp. 120691-120691
Closed Access | Times Cited: 35
Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 34
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors
Hany M. Abd El‐Lateef, Ayman Abo Elmaaty, Lina M. A. Abdel Ghany, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17948-17965
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top